HCWB Company Profile and Key Details
HCW Biologics Inc.
HCWB Stock Price Chart
Stock Price Today
HCW Biologics Inc. (HCWB) stock declined over -5.41%, trading at $0.35 on NASDAQ, down from the previous close of $0.37. The stock opened at $0.38, fluctuating between $0.33 and $0.39 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.
Company Information
| Employees | 45 |
| Beta | 0.84 |
| Sales or Revenue | $2.84M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
HCW Biologics Inc. (NASDAQ: HCWB) stock price is $0.35 in the last trading session. During the trading session, HCWB stock reached the peak price of $0.39 while $0.33 was the lowest point it dropped to. The percentage change in HCWB stock occurred in the recent session was -5.41% while the dollar amount for the price change in HCWB stock was -$0.02.
The NASDAQ listed HCWB is part of Biotechnology industry that operates in the broader Healthcare sector. HCW Biologics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Nicole Valdivieso Esq.
Vice President of Legal Affairs
Dr. Hing C. Wong Ph.D.
Founder, Chief Executive Officer, Director & Sec.
Ms. Raquel Diaz M.S.
Director of HR
Ms. Rebecca Byam CPA, M.B.A.
Chief Financial Officer
Dr. Peter Rhode Ph.D.
Chief Scientific Officer & Vice President of Clinical Operations
Mr. Lee D. Flowers
Senior Vice President of Bus. Devel.
HCWB's closing price is 26.81% higher than its 52-week low of $0.28 where as its distance from 52-week high of $2.52 is -86.11%.
Number of HCWB employees currently stands at 45.
Official Website of HCWB is: https://www.hcwbiologics.com
HCWB could be contacted at phone 954 842 2024 and can also be accessed through its website. HCWB operates from 2929 North Commerce Parkway, Miramar, FL 33025, United States.
HCWB stock volume for the day was 113.84K shares. The average number of HCWB shares traded daily for last 3 months was 9.89M.
The market value of HCWB currently stands at $13.24M with its latest stock price at $0.35 and 37.82M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com